What is Standard Chemical & Pharmaceutical Co Current Ratio?
Standard Chemical & Pharmaceutical CoTPE:1720 95 Current Ratio is 2.53 as of Dec. 2025, which is 23% above its 10-year median of 2.06. GuruFocus rates TPE:1720 with a GF Score™ of 95/100 and a GF Value™ of NT$70.94 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 1,000 Drug Manufacturers companies, Standard Chemical & Pharmaceutical Co ranks better than 60.7% on this metric.
TPE:1720's Current Ratio is ranked better than 60.7% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2
vs TPE:1720: 2.53
Standard Chemical & Pharmaceutical Co (TPE:1720) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Standard Chemical & Pharmaceutical Co Current Ratio Related Terms
Standard Chemical & Pharmaceutical Co Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co Current Ratio Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Standard Chemical & Pharmaceutical Co Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Current Ratio distribution charts can be found below:
* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Standard Chemical & Pharmaceutical Co (TPE:1720) has a Current Ratio of 2.53 as of Dec. 2025. This is 23% above median its historical median of 2.06. Over the past decade, Standard Chemical & Pharmaceutical Co's Current Ratio has ranged from 1.80 to 3.01. According to the industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #393 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 39.3%.
Is Standard Chemical & Pharmaceutical Co's Current Ratio too high?
Standard Chemical & Pharmaceutical Co's current Current Ratio of 2.53 is 23% above median its 10-year median of 2.06. Over the past 10 years, this metric has ranged from a low of 1.80 to a high of 3.01. The Drug Manufacturers industry median Current Ratio is 2.00. Standard Chemical & Pharmaceutical Co's value of 2.53 is 26.5% above this industry median. Based on the distribution chart, Standard Chemical & Pharmaceutical Co ranks #393 out of 1000 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Standard Chemical & Pharmaceutical Co has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Standard Chemical & Pharmaceutical Co's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Standard Chemical & Pharmaceutical Co ranks #393 out of 1000 companies for Current Ratio. This puts Standard Chemical & Pharmaceutical Co in the upper half of its industry. The industry median Current Ratio is 2.00. Standard Chemical & Pharmaceutical Co's value of 2.53 is 26.5% above this benchmark. Historically, Standard Chemical & Pharmaceutical Co's own Current Ratio has ranged from 1.80 to 3.01 over the past decade. While the company's 10-year median is 2.06 vs. the industry median of 2.00, Standard Chemical & Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Standard Chemical & Pharmaceutical Co's current Current Ratio of 2.53 is 26.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Standard Chemical & Pharmaceutical Co's current Current Ratio is 2.53, which is 23% above median its own 10-year median of 2.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Standard Chemical & Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co (TPE:1720) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$70.94, compared to a current price of NT$63.90 — trading 9.9% below its estimated fair value. The current Current Ratio is 2.53, which is 23% above median its 10-year median of 2.06 and 26.5% above the Drug Manufacturers industry median of 2.00. Standard Chemical & Pharmaceutical Co's overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Standard Chemical & Pharmaceutical Co (TPE:1720), the current Current Ratio is 2.53 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Standard Chemical & Pharmaceutical Co (TPE:1720) Overvalued in 2026?
Based on GuruFocus' analysis, Standard Chemical & Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$63.90 is trading 9.9% below its estimated GF Value™ of NT$70.94.
GuruFocus considers Standard Chemical & Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TPE:1720:
Current Ratio: 2.53 (23% above median its 10-year median of 2.06)
GF Value™: NT$70.94 vs. price of NT$63.90 (9.9% below fair value)
Industry Position: 26.5% above the Drug Manufacturers median (#393 of 1000)
No single metric tells the full story. See the TPE:1720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Standard Chemical & Pharmaceutical Co Business Description
Standard Chemical & Pharmaceutical Co Ltd is engaged in the manufacturing and sales of Chinese and western medicine, cosmetics, beverage, normal instruments and medical instruments. Its segments include Medicine, Dietary supplement and Ingredients. The majority of the revenue is derived from the Medicine segment. Geographically it operates in Taiwan, Japan and Others with Taiwan generating the maximum revenue.
95GF Score
Get the complete analysis for TPE:1720
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1720 has been successfully added to your 
